Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay S Raval

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 6, 2021
A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assayJay S Raval, Nathan D Montgomery, Marian A Rollins-Raval
Journal of Clinical Apheresis|April 20, 2026
Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney BiopsyJay S Raval, Marian A Rollins-Raval, Yara A Park
Journal of Clinical Apheresis|April 20, 2016
Registry development for thrombotic microangiopathies: Biting off more than can be chewed?Jay S Raval, Yara A Park, Edward C C Wong, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 9, 2014
Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed?Larry Nichols, Aaron Berg, Marian A Rollins-Raval, et al.
Transfusion|May 23, 2012
Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortalityJay S Raval, Joel B Nelson, Elen Woldemichael, et al.
Frontiers in Medicine|December 16, 2021
Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic AdvancesRobert W Maitta, Jay S Raval, Hollie M Reeves, et al.
American Journal of Hematology|September 16, 2014
Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpuraJay S Raval, Anand Padmanabhan, Johanna A Kremer Hovinga, et al.
Asian Journal of Transfusion Science|August 28, 2014
Complications following an unnecessary peri-operative plasma transfusion and literature reviewJay S Raval, Jonathan H Waters, Darrell J Triulzi, et al.
Journal of Clinical Apheresis|October 18, 2024
Therapeutic Plasma Exchange to Reverse Plasma Failure in Multiple Organ Dysfunction SyndromeMatthew J Foglia, Jay S Raval, Jan C Hofmann, et al.
Journal of Clinical Apheresis|August 1, 2016
Monitoring therapeutic apheresis utilization: Database versus registryJay S Raval, Marshall A Mazepa, Herbert C Whinna, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 6, 2021
A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assayJay S Raval, Nathan D Montgomery, Marian A Rollins-Raval
Journal of Clinical Apheresis|April 20, 2026
Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney BiopsyJay S Raval, Marian A Rollins-Raval, Yara A Park
Journal of Clinical Apheresis|April 20, 2016
Registry development for thrombotic microangiopathies: Biting off more than can be chewed?Jay S Raval, Yara A Park, Edward C C Wong, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 9, 2014
Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed?Larry Nichols, Aaron Berg, Marian A Rollins-Raval, et al.
Transfusion|May 23, 2012
Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortalityJay S Raval, Joel B Nelson, Elen Woldemichael, et al.
Frontiers in Medicine|December 16, 2021
Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic AdvancesRobert W Maitta, Jay S Raval, Hollie M Reeves, et al.
American Journal of Hematology|September 16, 2014
Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpuraJay S Raval, Anand Padmanabhan, Johanna A Kremer Hovinga, et al.
Asian Journal of Transfusion Science|August 28, 2014
Complications following an unnecessary peri-operative plasma transfusion and literature reviewJay S Raval, Jonathan H Waters, Darrell J Triulzi, et al.
Journal of Clinical Apheresis|October 18, 2024
Therapeutic Plasma Exchange to Reverse Plasma Failure in Multiple Organ Dysfunction SyndromeMatthew J Foglia, Jay S Raval, Jan C Hofmann, et al.
Journal of Clinical Apheresis|August 1, 2016
Monitoring therapeutic apheresis utilization: Database versus registryJay S Raval, Marshall A Mazepa, Herbert C Whinna, et al.
Pageof 15